30 results
424B3
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
21 Nov 23
Prospectus supplement
9:15am
basis;
completing research and preclinical and clinical development of AMTI’s product candidates;
obtaining specialty raw materials for use … or within budget.
AMTI depends on third-party suppliers for key raw materials used in its manufacturing processes, and the loss of these third-party
S-4/A
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
20 Nov 23
Registration of securities issued in business combination transactions (amended)
8:50am
and preclinical and clinical development of AMTI’s product candidates;
obtaining specialty raw materials for use in production of AMTI’s product … depends on third-party suppliers for key raw materials used in its manufacturing processes, and the loss of these third-party suppliers
S-4
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
7 Nov 23
Registration of securities issued in business combination transactions
4:45pm
and preclinical and clinical development of AMTI’s product candidates;
obtaining specialty raw materials for use in production of AMTI’s product … on third-party suppliers for key raw materials used in its manufacturing processes, and the loss of these third-party suppliers or their inability
424B4
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
11 Dec 20
Prospectus supplement with pricing info
1:38pm
States import tariffs also impacts our costs for raw materials. When we experience short-term increases in currency fluctuation, tariff increases
424B4
3oet 9x6on9a
11 Dec 20
Prospectus supplement with pricing info
12:00am